PCMC
CCXI

Paragon Capital Management (Colorado)’s ChemoCentryx, Inc. CCXI Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,166
Closed -$42K – 555
2021
Q4 		$42K Buy
+1,166
New +$40.9K 0.01% 361

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Paragon Capital Management (Colorado)'s CCXI Position: Q1 2022 in Review

Paragon Capital Management (Colorado) sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 1,166 shares — an estimated $42K sold.

Paragon Capital Management (Colorado) first reported a position in CCXI in Q4 2021 and held it in 1 quarter. The position peaked at $42K in Q4 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Paragon Capital Management (Colorado) reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 1,166 ChemoCentryx, Inc. shares in Q1 2022, an estimated $42K.
  • Paragon Capital Management (Colorado) first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 1 quarter.
  • Paragon Capital Management (Colorado)'s ChemoCentryx, Inc. position peaked at $42K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2022, filed 19 Apr 2022.